Atavistik Bio Funding: $180M Raised, Series A (2021)
Atavistik Bio is a Biotech company based in Cambridge. It has raised $180M in total funding. Latest round: Series A.
Atavistik Bio funding overview
Atavistik Bio is a Biotech company based in Cambridge. Atavistik Bio has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in August 2021. The round record for Atavistik Bio runs through 2021; nothing later has been disclosed. Investors on record include The Column Group, Lux Capital, Nextech Invest, Ltd.. 3 distinct backers are named across the disclosed rounds.
Atavistik Bio at a glance
Total raised
$180M
Latest round
Series A
Latest round date
August 2021
Industry
Biotech
Headquarters
Cambridge
Notable investors
The Column Group, Lux Capital, Nextech Invest, Ltd.
Frequently asked about Atavistik Bio funding
How much has Atavistik Bio raised?
Atavistik Bio has raised $180M in total disclosed funding across the rounds on record.
Who has invested in Atavistik Bio?
The Column Group, Lux Capital, Nextech Invest, Ltd. are named among the investors backing Atavistik Bio.
What was the latest Atavistik Bio funding round?
The most recent disclosed round is a Series A, announced in August 2021.
Where is Atavistik Bio based?
Atavistik Bio is based in Cambridge.
What sector does Atavistik Bio operate in?
Atavistik Bio is tracked under Biotech from Cambridge, with $180M in disclosed funding.
When did Atavistik Bio last raise?
The last disclosed Atavistik Bio round closed in August 2021 at Series A.
Atavistik Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Cambridge below to benchmark round size and investor mix.
